SciDoc Publishers | Open Access | Science Journals | Media Partners

International Journal of Diabetology & Vascular Disease Research (IJDVR)    IJDVR-2328-353X-01-001e

Diabetes Mellitus and male reproductive function: where we stand?



Marco G. Alves1, Pedro F. Oliveira1*

CICS – UBI – Health Sciences Research Centre, University of Beira Interior, 6201-506 Covilhã, Portugal.

*Corresponding Author

Pedro Fontes Oliveira
University of Beira Interior, Av. Infante D. Henrique, 6201-506 Covilhã, Portugal.
E-mail: pfobox@gmail.com

Article Type: Editorial
Received: January 29, 2013; Published: March 29, 2013;

Citation: Alves MG, Oliveira PF (2013) Diabetes Mellitus and male reproductive function: where we stand?. Int J Diabetol Vasc Dis Res. 1(1e), 1-2. doi: dx.doi.org/10.19070/2328-353X-130001e

Copyright: Oliveira PF© 2013. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Diabetes mellitus (DM) is a metabolic disorder caused by absolute (Type 1 diabetes) or relative (Type 2 diabe -tes) deficiency of insulin and is associated with altera -tions in carbohydrate, lipid and protein metabolism [1]. The disease has been closely related with a wide range of long-term systemic complications and co-morbidi -ties, such as renal failure or hypertension [2]. Thus, the study of DM implications in human health is a chal -lenge to experts of any field of research.

According to the latest factsheets from World Health Organization (WHO), DM is one of the most rapidly growing threats to public health in modern societies.Over the past twenty years, the global prevalence of DM has approximately increased six-fold and nearly 350 million people worldwide suffer with the disease.The WHO estimated that, in 2004, over 3 million peopledied from consequences of high blood sugar and estimates that DM-related deaths will increase by two thirds between 2008 and 2030 [1,3]. Nonetheless, the existing statistical data can be underestimated since the factors known to be responsible for the disease progression,such as obesity and lifestyle habits, may aggravate these numbers [2].

When we take a close look at fertility rates in modern societies, we observe that the increase incidence of DM is concurrent with the falling birth rates and decreased fertility [4, 5]. This fact is partly due to the alarming upraising of the number of men developing DM during the reproductive age. Indeed, the great majority of patients with type 1 diabetes (T1D) are diagnosed before the age of 30 [6] and there is an worrying number of childhood and adolescent with type 2 diabetes (T2D) [7]. Moreover, western lifestyle habits,together with the increasing obesity among young individualsstrongly contribute for the high incidence of T2D in youth [2]. DM is responsible for several biochemical and homeostasis alterations that may result in male subfertility and or infertility yet the real impact of DM on male reproductive health remains undisclosed.Although there is some controversy on the subject, the diabetic individuals are frequently described to possess some sexual neuropathies, such as reduction of sexual appetite [8],that are explained with lethargy and tiredness related with the hyperglycemic state. Other disorders such as erectile dysfunction(ED)[9] or retrograde ejaculation [10, 11] are also well known to occur in male diabetics. Nonetheless, when examining sperm parameters and sperm quality markers, the literature shows some conflicting results. There are several studies since the 70’s comparing young or adult diabetics with control individuals. While some studies report that diabetic men present lower sperm counts and significant differences in sperm motility and morphology [12], as well as in sperm volume and count[13], other report only a slight, non-significant, decrease in sperm counts, although sperm volume and motility are frequently lower [14]. Others reported that sperm count and concentration were increased in the ejaculated of diabetic individuals, although sperm motility and semen volume were decreased. Noteworthy,in these last studies, sperm morphology and motility were described to remain unaffected [15]. Yet, other more recent study reported no correlations between sperm motility and age, age of onset of T1D and duration. The same study reported also that several sperm motility parameters such as track speed, path velocity, progressive velocity, and lateral head displacement remained unchanged while others, such as linearity and linear index (which reveal the straightness of sperm swimming), were increased in diabetic men [16]. This study evidenced that the T1D effects in male fertility may be related to the disease complications and not the disease itself [16]. Interestingly, the sperm of diabetic individuals is reported to present high fructose and glucose content [14], but the relation between an ineffective metabolic control and the observed alterations in the semen was never established and therefore should deserve a special focus in the next years.An extensive study of spermatozoa cryopreservationfrom patients with various pathologies, reported that only sperm from diabetic men presented significant differences in sperm parameters [17], while a recent study reported no alterations in semen parameters from T1D and T2D individuals [6]. Nonetheless, these authors reported that sperm from diabetic men presented a higher level of damage in sperm nuclear and mitochondrial DNA [6]. Although most of the studies are focused on sperm parameters analysis, there is an important study from 1985, performed using testicular biopsies from impotent men with DM that reported ultrastructural lesions in Sertoli cells (SCs) cytoplasm and morphological changes in the interstitial compartment of diabetic men testes [18]. These anatomic,structural and morphological alterations suggested that diabetic men may suffer a disruption on the spermatogenic event resulting in the subfertility and/or infertility often associated with DM.

Even though there are apparent contradictory results concerning sperm parameters and the real impact of DM in male reproductive function, it is not consensual that DM effects are only reflected in sperm or in the ejaculated. Moreover, apart from the direct studies of sperm, new important findings have been reported using in vitro strategies. For instance, diabetic individuals are known to have fluctuations in sex hormones concentrations [19]. Recent in vitro studies with rat [20] and human [21] SCs showed that sex hormones are able to modulate these cells metabolism. This is very significant since SCs metabolism is a crucial event for a successful spermatogenesis. These cells are known as “nurse cells” since one of their main functions is to metabolize glucose into lactate that is then consumed by the developing germ cells [22]. Thus, the hormonal control of SCs metabolism has a direct effect on spermatogenesis [23] and should deserve special attention when studying metabolic diseases that are also related with hormonal (de)regulation. Moreover, diabetic individuals have severe insulin deregulations that should be taken in consideration when discussing the effects of DM. Euglycemia is very difficult to maintain in diabetic patients and hypoglycemia/hyperinsulinemia, as well as hyperinsulinemia/hypoglycemia, are common events that diabetic individuals may face daily. Therefore,insulin can have a major role in the male sexual dysfunction associated with DM. In fact, recent reports show that only a few hours of insulin deprivation can alter not only SCs glucose metabolism [24] and also completely suppresses in vitro acetate production [25]. The regulation performed by insulin in these crucial processes for a normal spermatogenesis is a clear evidence that the molecular mechanisms by which DM affects the male reproductive function may also be linked to insulin fluctuations and not only to glucose concentrations.

There is an urgent need for clarification if DM can alter sperm parameters and overall male reproductive function. Furthermore, there is also a lack of consensus concerning sperm analysis, and it has been recently discussed thatconventional sperm analysis is very limited and needs standardization before it can give definite answers relatively to the fertility status of individuals [26]. Besides, when assessing the effect of DM, there are several factors very difficult to control such as the duration of the disease, the glycemic levels, type of treatment, as well as all the comorbidities associated ,that may obscure the real impact of DM in male fertility.It is evident that not all diabetic men are infertile and sperm analysis is not able to give an absolute answer to the question. Nonetheless, the molecular mechanisms of spermatogenesis and sperm maturation might be altered even when conventional sperm parameters appear normal. Thus, it is imperative to focus not only in the mechanisms that have a direct effect in natural and assisted conception, such as DNA integrity and oxidative stress, but also in the molecular basis of the disease that may affect testicular cells, spermatogenesis,sperm production and sperm maturation. These molecular studies may not only open new insights on the DM effects in the male reproductive function, but also point toward possible therapeutic sites for intervention to decrease DM-related male subfertility and/or infertility.


References

  1. American Diabetes Association(2012) Diagnosis and classification of diabetes mellitus. Diabe -tes Care 35 Suppl 1(S64-71.
  2. Fatouros IG Mitrakou A (2012) 13 Obesity and Diabetes. Obesity: Prevention and Treatment 249.
  3. Diabetes Fact Sheet Nº 312, 2012, World Health Organization.
  4. Hamilton BE Ventura SJ (2006) Fertility and abortion rates in the United States, 1960-2002. International Journal of Andrology 29(1): 34-45.
  5. Lutz W (2006) Fertility rates and future population trends: will Europe’s birth rate recover or continue to decline? International Journal of Andrology 29(1): 25-33.
  6. Agbaje IM, Rogers DA, Mcvicar CM, Mcclure N, Atkinson AB, et al. (2007) Insulin dependant diabetes mellitus: implications for male reproductive function. Human Reproduction 22(7): 1871-7.
  7. Silink M (2002) Childhood diabetes: a global perspective. Hor -mone Research 57 Suppl 1(1-5.
  8. Kolodny RC, Kahn CB, Goldstein HH, Barnett DM (1974) Sexual dysfunction in diabetic men. Diabetes 23(4): 306-9.
  9. Sexton WJ Jarow JP (1997) Effect of diabetes mellitus upon male reproductive function. Urology 49(4): 508-13.
  10. Bourne RB, Kretzschmar WA, Esser JH (1971) Successful ar -tificial insemination in a diabetic with retrograde ejaculation. Fertility and Sterility 22(4): 275-7.
  11. Fedele D (2005) Therapy Insight: sexual and bladder dysfunc -tion associated with diabetes mellitus. Nature Clinical Practice Urology 2(6): 282-90; quiz 309.
  12. Bartak V, Josifko M, Horackova M (1975) Juvenile diabetes and human sperm quality. International Journal of Fertility 20(1): 30-2.
  13. Bartak V (1979) Sperm quality in adult diabetic men. Interna -tional Journal of Fertility 24(4): 226-32.
  14. Padron RS, Dambay A, Suarez R, Mas J (1984) Semen analyses in adolescent diabetic patients. Acta Diabetologica Latina 21(2): 115-21.
  15. Ali ST, Shaikh RN, Siddiqi NA, Siddiqi PQ (1993) Semen analysis in insulin-dependent/non-insulin-dependent diabetic men with/without neuropathy. Archives of Andrology 30(1): 47-54.
  16. Niven MJ, Hitman GA, Badenoch DF (1995) A study of sper-matozoal motility in type 1 diabetes mellitus. Diabetic Medicine 12(10): 921-4.
  17. Ranganathan P, Mahran AM, Hallak J, Agarwal A (2002) Sperm cryopreservation for men with nonmalignant, systemic diseases: a descriptive study. Journal of Andrology 23(1): 71-5.
  18. Cameron DF, Murray FT, Drylie DD (1985) Interstitial com -partment pathology and spermatogenic disruption in testes from impo -tent diabetic men. Anatomical Record 213(1): 53-62.
  19. Ding EL, Song Y, Malik VS, Liu S (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes. JAMA: the journal of the American Medical Association 295(11): 1288-1299.
  20. Rato L, Alves MG, Socorro S, Carvalho RA, Cavaco JE, et al. (2012) Metabolic modulation induced by oestradiol and DHT in imma -ture rat Sertoli cells cultured in vitro. Bioscience Reports 32(1): 61-9.
  21. Oliveira PF, Alves MG, Rato L, Silva J, Sa R, et al. (2011) In-fluence of 5alpha-dihydrotestosterone and 17beta-estradiol on human Sertoli cells metabolism. International Journal of Andrology 34(6 Pt 2): e612-20.
  22. Rato L, Alves MG, Socorro S, Duarte AI, Cavaco JE, et al. (2012) Metabolic regulation is important for spermatogenesis. Nat Rev Urol 9(6): 330-8.
  23. Alves MG, Rato L, Carvalho RA, Moreira PI, Socorro S, et al. (2013) Hormonal control of Sertoli cells metabolism regulates spermato -genesis. Cellular and Molecular Life Sciences DOI: 10.1007/s00018-012-1079-1.
  24. Oliveira PF, Alves MG, Rato L, Laurentino S, Silva J, et al. (2012) Effect of insulin deprivation on metabolism and metabolism-associated gene transcript levels of in vitro cultured human Sertoli cells. Biochimica et Biophysica Acta: Protein Structure and Molecular Enzy -mology 1820(2): 84-9.
  25. Alves MG, Socorro S, Silva J, Barros A, Sousa M, et al. (2012) In vitro cultured human Sertoli cells secrete high amounts of acetate that is stimulated by 17beta-estradiol and suppressed by insulin deprivation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1823(8): 1389-1394.
  26. Jequier AM (2005) Is quality assurance in semen analysis still really necessary? A clinician’s viewpoint. Human Reproduction 20(8): 2039-42.


         Indexed in

pubhub  CGS  indexcoop  
j-gate  DOAJ  Google_Scholar_logo

       Total Visitors

SciDoc Counter

Get in Touch

SciDoc Publishers
16192 Coastal Highway
Lewes, Delaware 19958
Tel :+1-(302)-703-1005
Fax :+1-(302)-351-7355
Email: contact.scidoc@scidoc.org


porn